Global Information
회사소개 | 문의

세계의 알츠하이머병 치료제 시장 : 동향, 기회, 예측(2015-2020년) - 영상, 치료법, 진단, 바이오마커

Global Alzheimer´s Drug Market: Trends, Opportunities and Forecasts 2015-2020

리서치사 Azoth Analytics
발행일 2015년 12월 상품 코드 346774
페이지 정보 영문 106 Pages
가격
US $ 2,000 ₩ 2,258,600 PDF by E-mail (Single User License)
US $ 3,000 ₩ 3,387,900 PDF by E-mail (Multi User License)


세계의 알츠하이머병 치료제 시장 : 동향, 기회, 예측(2015-2020년) - 영상, 치료법, 진단, 바이오마커 Global Alzheimer´s Drug Market: Trends, Opportunities and Forecasts 2015-2020
발행일 : 2015년 12월 페이지 정보 : 영문 106 Pages

세계의 알츠하이머병 시장은 2015-2020년 CAGR 8.54%로 성장할 전망입니다. 지역별로는 아시아태평양 지역이 2014년 매출 점유율의 대부분을 차자했으며, 2020년까지 이러한 경향이 계속될 것으로 예측됩니다.

세계의 알츠하이머병(Alzheimer's Disease) 시장에 대해 조사했으며, 시장 규모·점유율·예측, 부문별 분석(치료법, 진단 및 바이오마커, 영상 부문, 환자, 치료제) , 정책 및 규제 환경, 시장 동향 변화와 새로운 기회, 경쟁 구도와 전략적 제안, 주요 기업 개요 등의 정보를 전해드립니다.

제1장 조사 방법

제2장 알츠하이머병 시장 개요

제3장 세계의 알츠하이머병 시장 전망

제4장 세계의 알츠하이머병 시장

  • 치료법별
  • 진단법 및 바이오마커별
  • 영상 부문별
  • DMT(Disease Modifying Therapeutics)별

제5장 세계의 알츠하이머병 시장 전망 : 인구통계별(연령 그룹)

제6장 세계의 알츠하이머병 시장 전망 : 치료제별

제7장 세계의 알츠하이머병 시장 전망 : 지역별

제8장 미국의 알츠하이머병 시장 전망

  • 미국의 치매 시장 전망

제9장 세계의 치매 시장 전망

제10장 세계의 치매 시장 전망

  • 지역별 분석
    • 아시아태평양 지역의 치매 시장 전망
  • 국가별
    • 저소득국별 분석
    • 상위 10개국 분석

제11장 시장 역학

  • 성장 촉진요인
  • 과제

제12장 시장 동향과 발전

제13장 경쟁 구도

  • 매출 비교 : 상위 5개 기업
  • EBITDA 비교 : 상위 5개 기업
  • EBIT 비교 : 상위 5개 기업
  • PBT 비교 : 상위 5개 기업
  • PAT 비교 : 상위 5개 기업
  • 유동비율 비교 : 상위 5개 기업

제14장 기업 개요

  • Pfizer Inc.
  • Novartis International AG
  • Axovant Sciences Ltd.
  • Acadia Pharmaceuticals
  • Biotie Therapies

도표

KSM 16.01.06

Executive Summary

Progressive numbers of neurological disorders along with escalating demand for drugs to control of Alzheimer Disease.

The Global Alzheimer's Market is growing at a moderate rate over last five years on account of rising expenditure on health care especially neurological disorders among ageing population and escalating role of private and government bodies in empowering R&D measures to avoid degenerative disorders. During 2015-20, Global Alzheimer Disease Market is anticipated to grow at an increased rate on account of robust expansion plans of the increase in medical facilities. Moreover, increase in number of patients suffering from degenerative disorder is further anticipated to boost the Global Alzheimer's market in the coming years.

According to Azoth Analytics research report, “Global Alzheimer's Drug Market: Trends, Opportunities and Forecasts (2015-2020) - (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years; By Region; Global Dementia Market)”, global Alzheimer's market is projected to exhibit a CAGR of over 8.54% during 2015-2020. On the basis of Reisberg Scale, market is categorized by seven stages of Alzheimer. Alzheimer is expected to be cured by Drugs; Exercise and Nutrition. Growth in Alzheimer's Drug market is anticipated to grow in the next five years. Asia Pacific region dominated the revenue contribution share in 2014 and the region is forecast to continue its domination through 2020. Few of the leading companies operating in Global Alzheimer's Disease Market include Axovant Sciences Ltd., Biotie Therapies, Acadia Pharmaceuticals, Novartis International AG and many more.

Scope of the Report

The report “Global Alzheimer's Drug Market: Trends, Opportunities and Forecasts (2015-2020) - (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: >65 years, <65 years; By Region; Global Dementia Market)” analyzes the following aspects of global Alzheimer's market:

  • Global Alzheimer's Market Size, Share & Forecast
  • Segmental Analysis - By Therapeutics, By Diagnostics and Biomarkers, By Imaging Sector, By Patient and By Drugs
  • Policy & Regulatory Landscape
  • Market Entry Strategies for Domestic/Foreign Players
  • Changing Market Trends & Emerging Opportunities
  • Competitive Landscape & Strategic Recommendations

Why You Should Buy This Report?

  • 1. To gain an in-depth understanding of Alzheimer disease and dementia market propelling globally.
  • 2. To identify the on-going trends and anticipated growth in the next five years
  • 3. To help industry consultants, drug and diagnostics manufacturers, vendors and dealers align their market-centric strategies
  • 4. To obtain research based business decision and add weight to presentations and marketing material
  • 5. To gain competitive knowledge of leading players
  • 6. To avail limited customization in the report without any extra charges and get research data or trends added in the report as per the buyer's specific needs

Table of Contents

1. Research Methodology

2. Alzheimer's Disease Market Overview

3. Global Alzheimer's Disease Market Outlook

4. Global Alzheimer's Disease Market

  • 4.1. By Therapeutics
  • 4.2. By Diagnostics and Biomarkers
  • 4.3. By Imaging Sector
  • 4.4. By Disease Modifying Therapeutics

5. Global Alzheimer's Disease Market Outlook-By Demographic (Age-Group)

6. Global Alzheimer's Disease Market Outlook-By Drug

7. Global Alzheimer's Disease Market Outlook-By Region

8. United States Alzheimer's Disease Market Outlook

  • 8.1. United States Dementia Market Outlook

9. Global Dementia Disease Market Outlook

10. Global Dementia Disease Market Outlook

  • 10.1. By Regional Break-Up
    • 10.1.1. Asia-Pacific Dementia Market Outlook
  • 10.2. By Countries
    • 10.2.1. Low Income Country -wise Break up
    • 10.2.2. Top Ten Country-wise Break-Up
      • Australia Dementia Market Outlook
      • UK Dementia Market Outlook

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Sales Comparatives, Top 5 Companies
  • 13.2. EBITDA Comparatives, Top 5 Companies
  • 13.3. EBIT Comparatives, Top 5 Companies
  • 13.4. PBT Comparatives, Top 5 Companies
  • 13.5. PAT Comparatives, Top 5 Companies
  • 13.6. Current Ratio Comparatives, Top 5 Companies

14. Company Profiling

  • 14.1. Pfizer Inc.
  • 14.2. Novartis International AG
  • 14.3. Axovant Sciences Ltd.
  • 14.4. Acadia Pharmaceuticals
  • 14.5. Biotie Therapies
  • 1. Global Alzheimer's Disease Market Size ,By Value (USD Billion) and Volume (Number of Patients in Million) 2010-2020F
  • 2. Global Alzheimer's Disease Market by Therapeutics ,By Value (USD Million) 2010-2020F
  • 3. Global Alzheimer's Market share, By Therapeutics
  • 4. Global Alzheimer's Disease Market , By Diagnostics and Biomarkers ,By Value (USD Billion)
  • 5. Global Alzheimer's Disease Market, By Imaging Sector, By Value (USD Million)
  • 6. Global Alzheimer's Disease Market by Disease Modifying Therapeutics Market Size ,By Value (USD Million)
  • 7. Global Alzheimer's Disease Market, By Demographics, By Age < 65, By Volume (Number of patients in million),2010-2020F
  • 8. Global Alzheimer's Disease Market, By Demographics, By Age > 65, By Volume (Number of patients in million),2010-2020F
  • 9. Global Memantine (Nameda) Drug Market Size ,By Value (USD Billion) and Volume (Number of Patients in Million) 2010-2020F
  • 10. United States Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of Patients In Million) 2010-2020F
  • 11. Cost of Alzheimer Disease in United States, By Payer, By percentage, 2010-14
  • 12. U.S. Alzheimer's Drug RTV-101 Market , By Value & Penetration Rate; 2019-2027 (USD Million)
  • 13. U.S. Alzheimer's Drug Azeliragon Market, By Value & Penetration Rate, 2019-2027 (USD Million)
  • 14. U.S. Annual Alzheimer's Death Rates ,By Age; 2006-2013
  • 15. U.S. Annual Alzheimer's Death Rates ,By Age; 2006-2013
  • 16. Global Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of Patients In Million) 2010-2020F
  • 17. Global Dementia Disease Market Size , By Volume (Number of Patients In Million), By Region 2014
  • 18. Global Dementia Disease Market Size , By Number of new cases, By Volume (Number of Patients In Million), By Region 2014
  • 19. Asia-Pacific Dementia Disease Market Size , By Volume (Number of Patients In Million), By country 2015E,2030F,2050F
  • 20. Global Dementia Disease Market Size , By Volume (Number of Patients In Million), By Region 2014
  • 21. Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million) 2010-2020F
  • 22. Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million) 2010-2020F
  • 23. Global Dementia Disease Market Size in Top Ten Countries ,Volume (Number of Patients In Million) 2010-2020F
  • 24. Australia Dementia Disease Market Size , By Volume (Number of Patients In Million) 2010-2020F
  • 25. Australia Dementia Disease Market Size , By Volume (Number of Patients In Million) 2010-2020F
  • 26. UK Dementia Market, By Type, 2014 (%)
  • 27. UK Dementia Cost, By Type of Service, 2014 (%)
  • 28. Number of Unpaid Caregivers (In Million)
  • 29. Pfizer Revenue (USD Million) AY 2011-2014
  • 30. Axovant Services Ltd. Revenue (USD Million) FY 2011-2015
  • 31. Pfizer Percentage Revenue, By Business Segment (2014)
  • 32. Pfizer Percentage Revenue, By Geography (2014)
  • 33. Novartis International AG Revenue (USD Million) AY 2011-2014
  • 34. Novartis International AG Percentage Revenue, By Business Segment (2014)
  • 35. Novartis International AG Percentage Revenue, By Geography (2014)
  • 36. Axovant Services Ltd. Revenue (USD Million) FY 2011-2015
  • 37. Axovant Services Ltd. Percentage Revenue, By Business Segment (2014)
  • 38. Axovant Services Ltd. Percentage Revenue, By Geography (2014)
  • 39. Acadia Pharmaceuticals Revenue (USD Million) AY 2011-2014
  • 40. Acadia Pharmaceuticals Percentage Revenue, By Business Segment (2014)
  • 41. Acadia Pharmaceuticals Percentage Revenue, By Geography (2014)
  • 42. Biotie Therapies Revenue (USD Million) AY 2011-2014
  • 43. Biotie Therapies Percentage Revenue, By Business Segment (2014)
  • 44. Sales Comparatives, Top 5 Companies, 2011-2014
  • 45. EBITDA Comparatives, Top 5 Companies, 2011-2015
  • 46. EBIT Comparatives, Top 5 Companies, 2011-2015
  • 47. PBT Comparatives, Top 5 Companies, 2011-2015
  • 48. PAT Comparatives, Top 5 Companies, 2011-2015
  • 49. Current Ratio Comparatives, Top 5 Companies, 2011-2015
  • 50. Profit Margin Ratio Comparatives, Top 5 Companies, 2011-2015
  • 51. Debt Equity Ratio Comparatives, Top 5 Companies, 2011-2015
Back to Top
전화 문의
이용안내
 
BCC Research